Fact based stock research
Raffles Medical Group (SGX:BSL)

SG1CH4000003

Raffles Medical Group stock research in summary

rafflesmedicalgroup.com/raffles-medical-group


Raffles Medical Group shares are less expensive than other comparable stocks. While they are good value, they show below average growth, and are riskily financed. We recommend evaluating whether the future of the company Raffles Medical Group is really as difficult as the low price of the stock suggests. If you believe that the future of the company is market-typical or even better, then this could be an argument for a share purchase.


Latest Obermatt Ranks


Value Rank 73
Growth Rank 47
Safety Rank 40
Combined Rank 51
Country Singapore
Industry Health Care Facilities
Index
Size class Medium

June 4, 2021. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist
Filter Similar Stocks
Similar Top 10

Google: Raffles Medical Group

News

Videos

Wikipedia about Raffles Medical Group

Management

Employee Satisfaction

Customer Satisfaction

Research History: Raffles Medical Group

RESEARCH HISTORY 2018 2019 2020 2021
VALUE
VALUE n/a
n/a
65
73
GROWTH
GROWTH n/a
n/a
24
47
SAFETY
SAFETY n/a
n/a
41
40
COMBINED
COMBINED n/a
n/a
37
51

Last update of Combined Rank: 4-Jun-2021. Financial reporting date used for calculating ranks: 31-Dec-2020. Stock research history is based on the Obermatt Method. The higher the rank, the better Raffles Medical Group is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2018 2019 2020 2021
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S) n/a
n/a
40
43
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E) n/a
n/a
58
63
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book) n/a
n/a
67
68
DIVIDEND YIELD
DIVIDEND YIELD n/a
n/a
80
88
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE n/a
n/a
65
73

Last update of Value Rank: 4-Jun-2021. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Raffles Medical Group; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2018 2019 2020 2021
REVENUE GROWTH
REVENUE GROWTH n/a
n/a
34
55
PROFIT GROWTH
PROFIT GROWTH n/a
n/a
24
38
STOCK RETURNS
STOCK RETURNS n/a
n/a
27
40
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH n/a
n/a
24
47

Last update of Growth Rank: 31-Dec-2020. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Raffles Medical Group.


Safety Metrics in Detail

SAFETY METRICS 2018 2019 2020 2021
LEVERAGE
LEVERAGE n/a
n/a
53
52
REFINANCING
REFINANCING n/a
n/a
16
16
LIQUIDITY
LIQUIDITY n/a
n/a
66
70
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY n/a
n/a
41
40

Last update of Safety Rank: 28-May-2021. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Raffles Medical Group and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Raffles Medical Group from June 4, 2021.


We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.

Get stock news now

Investing made easy